D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

June 30, 2002

Study Completion Date

March 31, 2004

Conditions
FatigueNeoplasms
Interventions
DRUG

dexmethylphenidate(d-mph)

Trial Locations (21)

10003

Beth Israel Cancer Center, New York

21215

Sinai Hospital of Baltimore, Baltimore

29604

Gynecologic Oncology Associates and Development LLC, Greenville

30309

Piedmont Hospital, Atlanta

32901

Osler Clinical Research/Osler Medical Inc, Melbourne

33139

University of Miami, Sylvester Cancer Research Center, Miami

33162

H. Lee Moffitt Cancer Center and Research Institute, Tampa

33324

Cancer Research Network Inc, Plantation

33428

Comprehensive Cancer Center, Boca Raton

35233

Cooper Green Hospital, Jefferson Clinic, Birmingham

40536

Markey Cancer Center, Lexington

85712

Arizona Clinical Research Center, Tucson

86004

Peak Performance Wellness, Flagstaff

90640

Clinical Trials and Research Associates, Montebello

92262

Comprehensive Cancer Centers of the Desert, Palm Springs

94704

Alta Bates Comprehensive Cancer Center, Berkeley

98405

Northwest Medical Specialists, PLLC, Tacoma

35294-0023

University of Alabama Palliative Care Institute, Birmingham

94904-2007

California Cancer Care Inc, Greenbrae

98109-1023

Seattle Cancer Care Alliance, Seattle

53792-6164

UW Comprehensive Cancer Center, Madison

Sponsors
All Listed Sponsors
lead

Celgene Corporation

INDUSTRY